Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2008
10/22/2008CN101289477A N-phenylpropenoyl chitosan oligosaccharide and preparation thereof
10/22/2008CN101289442A Novel benzoimidazole derivatives useful as antiproliferative agents
10/22/2008CN101288758A Analgesic medicine
10/22/2008CN101288739A Decoction for treating liver wind headache
10/22/2008CN101288735A Chinese medicinal composition for treating lupus erythermatosus and its preparation method
10/22/2008CN101288728A Plaster for treating rheumatism, rheumatoid, a variety of hyperosteogenys
10/22/2008CN101288715A Orally-taken Chinese medicine for treating headache due to wind-heat evil
10/22/2008CN101288695A Preparation technique of alkaloids from Stephania tetrandra
10/22/2008CN101288694A Preparation method of magnolia bark extracts with no residual solvent, low oiliness and high content
10/22/2008CN101288690A Anti-inflammation, anti-sensitivity, anti-shock medicament and preparation method thereof
10/22/2008CN101288688A Chinese medicinal preparation for treating headache due to deficiency of blood
10/22/2008CN101288665A Medicine containing alkannin compound as active component
10/22/2008CN101288664A Preparation method of magnetic nano microcapsule with nucleus/shell structure
10/22/2008CN101288657A Troxerutin-cumarin sustained-release drop pills and preparation method thereof
10/22/2008CN101288645A Tilidine medicine resin oral turbid suspension and preparation method thereof
10/22/2008CN100427504C TNF alpha high-affinity chimeric antibody and use thereof
10/22/2008CN100427488C Adenine kind derivative and its synthesis method
10/22/2008CN100427475C Naproxen-2-aryl morpholine ethyl ester and its preparation method and uses
10/22/2008CN100427469C Quinoline derivatives as neutrophil elastase inhibitors and their use
10/22/2008CN100427140C Freeze-drying powder injection of Bozhi glycopeptide and its preparation
10/22/2008CN100427133C Externally applied medicine for cutting therapy
10/22/2008CN100427131C Ointment for treating traumatic injury and its preparation method
10/22/2008CN100427128C Babu paste of Chinese medicine for child to reduce fever and its making method
10/22/2008CN100427121C Resina draconis and its total flavone solution preparation and its preparation method
10/22/2008CN100427120C Plaster for treating neck, shoulder and waist and leg pain and its preparing method
10/22/2008CN100427108C Rheumatism treating medicine and its prepn process
10/22/2008CN100427093C 4(2-butylamino)-2,7-dimethyl-8-(2-methyl(-6-methoxyp-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine as corticotropin releasing factor receptor
10/22/2008CN100427089C Use of indazole derivatives for the treatment of neuropathic pain
10/22/2008CN100427085C (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
10/22/2008CN100427063C An wind-expelling ointment and method for preparing same
10/21/2008US7439356 Substituted indan derivatives
10/21/2008US7439331 Inhibition of complement activation
10/21/2008US7439251 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
10/21/2008US7439240 Reversible inhibitors of cysteine proteases S, K, F, L and B; inhibiting Cathepsin S; analgesics; 1-[9-(4-Chlorophenyl)-2-cyano-9H-purin-6-yl]-L-prolinamide for example
10/21/2008CA2468847C Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
10/21/2008CA2282345C Pharmaceutical composition
10/21/2008CA2247998C Fragments of cr1 and their use
10/21/2008CA2232294C Bioactive factors of aloe vera plants
10/21/2008CA2174472C Arylalkylpyridazinones
10/16/2008WO2008124153A1 Heteroaryl amide analogues as p2x7 antagonists
10/16/2008WO2008123582A1 Tetrahydroisoquinoline compound
10/16/2008WO2008123396A1 Suspension-type eye drop preparation comprising fluorometholone
10/16/2008WO2008123231A1 Novel cyclic staple-type oligonucleotide, and nf-κb decoy comprising the same
10/16/2008WO2008123017A1 Novel diamide derivative
10/16/2008WO2008122810A1 Phthalazinone derivatives and their use as medicament to treat cancer
10/16/2008WO2008122119A1 Perfluoroketone compounds and uses thereof
10/16/2008WO2008089268A3 Methods and compositions for treating conditions associated with infection and/or inflammation
10/16/2008US20080255248 Coupling a stabilizing group-oligopeptide conjugate with the free therapeutic agent, binding with a polymeric resin forming a therapeutic agent-polymeric resin complex; high specificity of action, a reduced toxicity, an improved stability in the serum and blood
10/16/2008US20080255225 Botanical Extract Composition
10/16/2008US20080255222 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
10/16/2008US20080255209 Combination of a NSAID and a PDE-4 inhibitor
10/16/2008US20080255191 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/16/2008US20080255163 Compounds such as 2-piperidino-6-methyl-5-oxo-5,6-dihydro-(7H) pyrrole-[3,4-d]pyrimidine maleate (MS-818); nervous system, brain, and neurodegenerative disorders; Parkinson's, Alzheimer's, and Huntington's disease
10/16/2008US20080255146 Macrolide compounds comprising 18,19-epoxytricosa-8,12,14-trien-11-olide derivatives; angiogenesis inhibitors; anticarcinogenic, antimetastasis, antiinflammatory, and antitumor agents; antihypoxic agents; endothelial growth factor suppressors; retinal neovascularization, diabetic retinopathy
10/16/2008US20080255141 Modulators of signal transduction mediated by certain native and/or mutant tyrosine kinases; antiproliferative, anticarcinogenic, antiallergen, and antiinflammatory agents; metabolic and neurodegenerative disorders
10/16/2008US20080255129 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics
10/16/2008US20080255123 (2Z)-2-(3-butyl-4,5-dimethyl-1,3-thiazol-2(3H)-ylidene)-1-(5-chloro-2-methoxyphenyl)ethanone; antiinflammatory, analgesic agent; autoimmune diseases; neuroprotectants
10/16/2008US20080255121 Combination Drug for Treating Autoimmune Disease
10/16/2008US20080255114 2-aminobenzoxazole carboxamides as 5ht3 modulators
10/16/2008US20080255110 Imidazoquinoline derivatives as adenosine a3 receptor ligands
10/16/2008US20080255104 Nsaid Compositions
10/16/2008US20080255042 CaSR Antagonist
10/16/2008US20080255028 Collagen Receptor I-Domain Binding Modulators
10/16/2008US20080255025 Protease inhibition
10/16/2008US20080254506 Claudin polypeptides
10/16/2008US20080254157 Herbal composition for inflammatory disorders
10/16/2008US20080254154 Comprising Cucurbita moschata, Carthamus tinctorius, Plantago asiatica and Lonicera japonica; climacteric disturbance, primary hypogonadism (including ovarian hypofunction and testicular deficiency), Turner's syndrome, Klinefelter's syndrome, gonadotropin-producing tumor, testitis, ovarian amenorrhea
10/16/2008US20080254127 Inhalation particles incorporating a combination of two or more active ingredients
10/16/2008US20080254123 Morphine polymer release system
10/16/2008US20080254110 Composition For Enhancing Immunity and Reducing Inflammation Related to Infections
10/16/2008US20080254105 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
10/16/2008US20080254039 Prevention of Thrombus Formation and/or Stabilization
10/16/2008US20080254032 Colony stimulating bfcator specific monoclonal antibody for use in diagnosis, prevention and treatment of infcetion, cell proliferative, inflammatory, autoimmune, arthritic, skin, respiratory and nervous system disorders
10/16/2008US20080254028 Caspase-8 interacting polypeptide (Cari) for use in identifying modulators for prevention and treatment of autoimmune, inflammatory, connective tissue and liver disorders
10/16/2008US20080254025 Using interleukin-1( IL-1) specific immunoglobulin for diagnosis, prevention and treatment of osteoarthritic, inflammatory, respiratory and autoimmune disorders
10/16/2008DE102007017884A1 Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln New vanilloid receptor ligands and their use for the preparation of medicaments
10/16/2008CA2683682A1 Phthalazinone derivatives and their use as medicament to treat cancer
10/16/2008CA2682925A1 Heteroaryl amide analogues
10/15/2008EP1980271A1 Medicine for transnasal administration
10/15/2008EP1979367A2 Quinolin-4-one derivatives as modulators of abc transporters
10/15/2008EP1979316A1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists
10/15/2008EP1978934A1 Bursting pellets
10/15/2008EP1603901B1 Tetrahydropyran compounds as tachykinin antagonists
10/15/2008EP1490069B1 Alpha aed and beta aed regulation of nuclear transcription, gene regulation, and/or gene expression
10/15/2008EP1458723B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/15/2008EP1458722B1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
10/15/2008EP1453798B1 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
10/15/2008EP1444202B1 Novel metalloproteinase inhibitors
10/15/2008EP1427409B1 Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s)
10/15/2008EP1383786B1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
10/15/2008EP1373257B9 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/15/2008EP1372704B1 Monocyte-specific particulate delivery vehicle
10/15/2008EP1319008B1 Water soluble rapamycin esters
10/15/2008EP1272515B1 Immunoregulator
10/15/2008EP0841946B2 Methods for treatment of allergic asthma
10/15/2008CN101287741A Heterobifunctional pan-selectin inhibitors
10/15/2008CN101287723A Amide alkyl pyridiyl quinolines as nk3 receptor modulators
10/15/2008CN101287718A Substituted heteroaryl- and phenylsulfamoyl compounds
10/15/2008CN101287712A Heterocyclic compounds
10/15/2008CN101287454A Iontophoresis preparation for treatment of breast cancer and/or mastitis
1 ... 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 ... 1272